Treatment of High-Risk Acute Lymphoblastic Leukemia. Preliminary Results of the Protocol PETHEMA ALL-93
- 1 January 1998
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The GIMEMA ALL 0183 trial: analysis of 10‐year follow‐upBritish Journal of Haematology, 1996
- Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donorsBritish Journal of Haematology, 1994
- Acute lymphocytic leukaemia in the elderly: characteristics and outsome with the vincristine‐adriamycin‐dexamethasone (VAD) regimenBritish Journal of Haematology, 1994
- Estimatetd 8‐year survival of more than 40% in a population‐based study of 79 adult patients with acute lymphoblastic leukaemiaBritish Journal of Haematology, 1994
- Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult LeukaemiaBritish Journal of Haematology, 1993
- Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemiaBritish Journal of Haematology, 1990
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence DataBiometrics, 1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958